Literature DB >> 7868005

The pathophysiology of cocaine cardiotoxicity.

A F Rump1, M Theisohn, W Klaus.   

Abstract

Cocaine use is accompanied by a high risk of serious adverse effects involving the cardiovascular system. The basic cellular mechanisms of cocaine consist in [1] a potentiation of catecholamine effects by inhibition of the presynaptic uptake carrier [2] local anesthetic effects by the block of sodium-channels. Acute ischemic events can be induced by cocaine through coronary spasms in a situation of physiologic stress already accompanied by an enhanced myocardial oxygen demand. Procoagulant properties of cocaine may, moreover, favor coronary thrombosis formation and the development of myocardial infarction. Ischemia, reperfusion and the direct action of catecholamines on cardiocytes are accompanied by enhanced cytoplasmic calcium levels, inducing delayed after-potentials, repetitive action-potential generation and premature ventricular beats. Conduction velocity impairments caused by the local anesthetic effects of cocaine and inhomogeneous repolarization phenomena related to potassium channel inhibition may form a substrate for re-entrant circuits inducing ventricular fibrillation. Cocaine abuse may also cause degenerative and inflammatory alterations of the myocardium. Besides secondary ischemic changes, hypersensitivity-myocarditis and toxic cardiomyopathies that may be due to the cardiotoxic effects of catecholamines have been described in cocaine abusers. Moreover, persons using cocaine intravenously seem to be particularly endangered by bacterial endocarditis compared to the users of other intravenous drugs, for still unknown reasons.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7868005     DOI: 10.1016/0379-0738(94)01638-l

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  7 in total

1.  Pioglitazone attenuates acute cocaine toxicity in rat isolated heart: potential protection by metabolic modulation.

Authors:  Guy L Weinberg; Richard Ripper; Sarah Bern; Bocheng Lin; Lucas Edelman; Guido Digregorio; Mariann Piano; Douglas L Feinstein
Journal:  Anesthesiology       Date:  2011-06       Impact factor: 7.892

Review 2.  Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity.

Authors:  Lucas Liaudet; Belinda Calderari; Pal Pacher
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

Review 3.  Sudden adult death.

Authors:  Neil E I Langlois
Journal:  Forensic Sci Med Pathol       Date:  2009-07-18       Impact factor: 2.007

Review 4.  Psychostimulants and cognition: a continuum of behavioral and cognitive activation.

Authors:  Suzanne Wood; Jennifer R Sage; Tristan Shuman; Stephan G Anagnostaras
Journal:  Pharmacol Rev       Date:  2013-12-16       Impact factor: 25.468

Review 5.  Cardiovascular complications of cocaine: imaging findings.

Authors:  Carlos S Restrepo; Carlos A Rojas; Santiago Martinez; Roy Riascos; Alejandro Marmol-Velez; Jorge Carrillo; Daniel Vargas
Journal:  Emerg Radiol       Date:  2008-09-05

6.  Fate of systemically administered cocaine in nonhuman primates treated with the dAd5GNE anticocaine vaccine.

Authors:  Martin J Hicks; Stephen M Kaminsky; Bishnu P De; Jonathan B Rosenberg; Suzette M Evans; Richard W Foltin; David M Andrenyak; David E Moody; George F Koob; Kim D Janda; Rodolfo J Ricart Arbona; Michelle L Lepherd; Ronald G Crystal
Journal:  Hum Gene Ther Clin Dev       Date:  2014-03       Impact factor: 5.032

7.  Cocaine vaccine dAd5GNE protects against moderate daily and high-dose "binge" cocaine use.

Authors:  David F Havlicek; Jonathan B Rosenberg; Bishnu P De; Martin J Hicks; Dolan Sondhi; Stephen M Kaminsky; Ronald G Crystal
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.